NCT03988335 - A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 13, 2019

Primary Completion Date

November 5, 2019

Study Completion Date

November 19, 2019

Conditions

Palmoplantar Pustulosis

Interventions

DRUG

RIST4721

RIST4721 oral solution

DRUG

Placebo

Placebo oral solution

Trial Locations (17)

10783

Rothhaar Studien GmbH, Berlin

22391

MensingDerma research GmbH, Hamburg

44793

Hautarztpraxis Dr. Niesmann & Dr. Othlinghaus, Bochum

48455

Fachklinik Bad Bentheim, Bad Bentheim

94315

Hautarztpraxis Dr. Wilfried Steinborn, Straubing

T2G 1B1

Kirk Barber Research, Calgary

T6G 1C3

Alberta DermaSurgery Centre, Edmonton

T4N 6V7

CARe Clinic (Central Alberta Research Clinic), Red Deer

R3C 0N2

Winnipeg Clinic, Winnipeg

E3B 1G9

Brunswick Dermatology Center, Fredericton

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Center, Barrie

P3A 1W8

Dr. Lyne Giroux Medicine Professional Corporation, Greater Sudbury

L3P 1X2

Lynderm Research Inc., Markham

P1B 3Z7

North Bay Dermatology Centre, North Bay

L4C 9M7

York Dermatology Center, Richmond Hill

H2X 2V1

Innovaderm Research Inc., Montreal

J7Z 3B8

Dre Angelique Gagne-Henley MD Inc., Saint-Jérôme